Notice of Closed Meeting, 428 [2019-00198]
Download as PDF
<![CDATA[
428
Federal Register / Vol. 84, No. 18 / Monday, January 28, 2019 / Notices
identified by Docket No. CDC–201x–
xxxx using the Federal eRulemaking
Portal: https://www.regulations.gov.
Follow the instructions for submitting
comments. All submissions received
must include the agency name and
Docket Number. All relevant comments
received in conformance with the
regulations.gov suitability policy will be
posted without change to https://
regulations.gov, including any personal
information provided. For access to the
docket to read background documents
or comments received, go to https://
www.regulations.gov. Written public
comments submitted by 72 hours prior
to the ACIP meeting will be provided to
the ACIP members before the meeting.
Matters to be Considered: The agenda
will include discussions on human
papillomavirus vaccines, pneumococcal
vaccines, Japanese encephalitis
vaccines, influenza vaccines, anthrax
vaccine, hepatitis vaccines, Pertussis
vaccine, herpes zoster vaccine, and
meningococcal vaccines. A
recommendation vote is scheduled for
anthrax vaccine, Japanese encephalitis
vaccines, and human papillomavirus
vaccines. Agenda items are subject to
change as priorities dictate. For more
information on the meeting agenda visit
https://www.cdc.gov/vaccines/acip/
meetings/meetings-info.html.
The Chief Operating Officer, Centers
for Disease Control and Prevention, has
been delegated the authority to sign
Federal Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Sherri A. Berger,
Chief Operating Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2019–00197 Filed 1–25–19; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
amozie on DSK3GDR082PROD with NOTICES1
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Chief Operating Officer, CDC,
pursuant to Public Law 92–463. The
16:01 Jan 25, 2019
Jkt 247001
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications and/or contract proposals,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Disease, Disability,
and Injury Prevention and Control Special
Emphasis Panel; (SEP)—PAR 15–303,
Occupational Safety and Health Education
and Research Centers (ERC).
Dates and Times: February 11, 2019, 6:00
p.m.–8:00 p.m. EST, February 12–13, 2019,
8:30 a.m.–5:00 p.m. EST.
Place: Hilton Alexandria Old Town, 1767
King Street, Alexandria, Virginia 22314,
(703)837–0440.
Agenda: To review and evaluate grant
applications.
For Further Information Contact: Michael
Goldcamp, Ph.D., Scientific Review Officer,
Office of Extramural Programs, CDC, 1095
Willowdale Road, Morgantown, West
Virginia 26505, (304) 285–5951;
mgoldcamp@cdc.gov.
The Chief Operating Officer, Centers for
Disease Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for both
the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Name of Committee: Fogarty International
Center Advisory Board.
Date: February 11–12, 2019.
Closed: February 11, 2019, 1:00 p.m. to
5:00 p.m.
Agenda: Second level review of grant
applications.
Place: National Institutes of Health,
Lawton L. Chiles International House,
Building 16, Conference Room, 16 Center
Drive, Bethesda, MD 20892.
Open: February 12, 2019, 9:00 a.m. to 3:00
p.m.
Agenda: Update and discussion of current
and planned FIC activities.
Place: National Institutes of Health,
Lawton L. Chiles International House,
Building 16, Conference Room, 16 Center
Drive, Bethesda, MD 20892.
Contact Person: Kristen Weymouth,
Executive Secretary, Fogarty International
Center, National Institutes of Health, 31
Center Drive, Room B2C02, Bethesda, MD
20892, (301) 496–1415, weymouthk@
mail.nih.gov.
This meeting notice is being published less
than 15 days in advance of the meeting due
to the partial Government shutdown of
December 2018.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page: https://
www.fic.nih.gov/About/Advisory/Pages/
default.aspx, where an agenda and any
additional information for the meeting will
be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.106, Minority International
Research Training Grant in the Biomedical
and Behavioral Sciences; 93.154, Special
International Postdoctoral Research Program
in Acquired Immunodeficiency Syndrome;
93.168, International Cooperative
Biodiversity Groups Program; 93.934, Fogarty
International Research Collaboration Award;
93.989, Senior International Fellowship
Awards Program, National Institutes of
Health, HHS)
Sherri Berger,
Chief Operating Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2019–00198 Filed 1–25–19; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Fogarty International Center Notice of
Meeting
BILLING CODE 4163–18–P
VerDate Sep<11>2014
grant applications and the discussions
could disclose confidential trade secrets
or commercial property such as
patentable material, and personal
information concerning individuals
associated with the grant applications,
the disclosure of which would
constitute a clearly unwarranted
invasion of privacy.
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Fogarty International
Center Advisory Board. The meeting
will be open to the public as indicated
below, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications
and/or contract proposals and the
PO 00000
Frm 00018
Fmt 4703
Sfmt 4703
E:\FR\FM\28JAN1.SGM
28JAN1
]]>Agencies
[Federal Register Volume 84, Number 18 (Monday, January 28, 2019)]
[Notices]
[Page 428]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-00198]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended, and the Determination of the Chief Operating
Officer, CDC, pursuant to Public Law 92-463. The grant applications and
the discussions could disclose confidential trade secrets or commercial
property such as patentable material, and personal information
concerning individuals associated with the grant applications, the
disclosure of which would constitute a clearly unwarranted invasion of
privacy.
Name of Committee: Disease, Disability, and Injury Prevention
and Control Special Emphasis Panel; (SEP)--PAR 15-303, Occupational
Safety and Health Education and Research Centers (ERC).
Dates and Times: February 11, 2019, 6:00 p.m.-8:00 p.m. EST,
February 12-13, 2019, 8:30 a.m.-5:00 p.m. EST.
Place: Hilton Alexandria Old Town, 1767 King Street, Alexandria,
Virginia 22314, (703)837-0440.
Agenda: To review and evaluate grant applications.
For Further Information Contact: Michael Goldcamp, Ph.D.,
Scientific Review Officer, Office of Extramural Programs, CDC, 1095
Willowdale Road, Morgantown, West Virginia 26505, (304) 285-5951;
mgoldcamp@cdc.gov.
The Chief Operating Officer, Centers for Disease Control and
Prevention, has been delegated the authority to sign Federal
Register notices pertaining to announcements of meetings and other
committee management activities, for both the Centers for Disease
Control and Prevention and the Agency for Toxic Substances and
Disease Registry.
Sherri Berger,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2019-00198 Filed 1-25-19; 8:45 am]
BILLING CODE 4163-18-P
